Global Health
Shareholders Ask Nine Pharma Companies to Report on Whether Patent Protections are Reducing People's Access to Medicines
Big food’s unhealthy products leave bitter taste for ESG investors
'Our worst nightmare realized:' Investors, WHO slam J&J for exporting COVID shots produced in Africa
Pfizer and Moderna urged to share vaccine technology with developing world
Investors lose vote to share Covid vaccine know-how
'These lives matter': Oxfam and partners urge J&J, Pfizer and Moderna investors to focus on vaccine equity efforts
'Betrayal of public trust': Pfizer under fire for resisting Paxlovid compulsory license
Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
Pages
